Wordt geladen...
Galectin-3 is a candidate biomarker for ALS: Discovery by a proteomics approach
The discovery of biomarkers for neurodegenerative diseases will have a major impact on the efficiency of therapeutic clinical trials, and may be important for understanding basic pathogenic mechanisms. We have approached the discovery of protein biomarkers for amyotrophic lateral sclerosis (ALS) by...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2948604/ https://ncbi.nlm.nih.gov/pubmed/20698585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/pr100409r |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|